The global Bladder Cancer Therapeutics market was valued at US$ 3238.6 million in 2022 and is projected to reach US$ 4052.8 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Bladder Cancer Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Bladder Cancer Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Bladder Cancer Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.
This report aims to provide a comprehensive presentation of the global market for Bladder Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bladder Cancer Therapeutics. This report contains market size and forecasts of Bladder Cancer Therapeutics in global, including the following market information:
- Global Bladder Cancer Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This in turn, will help in avoiding side effects of these drugs on healthy cells. With a better understanding of tumor immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma. One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called
cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as flexible
cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bladder Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bladder Cancer Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Bladder Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Transitional Cell Bladder Cancer
- Invasive Bladder Cancer
- Superficial Bladder Cancer
- Squamous Cell Bladder Cancer
- Others
Global Bladder Cancer Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Bladder Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Global Bladder Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Bladder Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bladder Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Bladder Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Eli Lilly
- F. Hoffman-La Roche
- Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bladder Cancer Therapeutics, market overview.
Chapter 2: Global Bladder Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Bladder Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bladder Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bladder Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bladder Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bladder Cancer Therapeutics Overall Market Size
2.1 Global Bladder Cancer Therapeutics Market Size: 2022 VS 2032
2.2 Global Bladder Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bladder Cancer Therapeutics Players in Global Market
3.2 Top Global Bladder Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Bladder Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Bladder Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bladder Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bladder Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Bladder Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Bladder Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bladder Cancer Therapeutics Market Size Markets, 2022 & 2032
4.1.2 Transitional Cell Bladder Cancer
4.1.3 Invasive Bladder Cancer
4.1.4 Superficial Bladder Cancer
4.1.5 Squamous Cell Bladder Cancer
4.1.6 Others
4.2 By Type - Global Bladder Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Bladder Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Bladder Cancer Therapeutics Revenue, 2024-2032
4.2.3 By Type - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bladder Cancer Therapeutics Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Bladder Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Bladder Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Bladder Cancer Therapeutics Revenue, 2024-2032
5.2.3 By Application - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Bladder Cancer Therapeutics Market Size, 2022 & 2032
6.2 By Region - Global Bladder Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Bladder Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Bladder Cancer Therapeutics Revenue, 2024-2032
6.2.3 By Region - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Bladder Cancer Therapeutics Revenue, 2018-2032
6.3.2 US Bladder Cancer Therapeutics Market Size, 2018-2032
6.3.3 Canada Bladder Cancer Therapeutics Market Size, 2018-2032
6.3.4 Mexico Bladder Cancer Therapeutics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Bladder Cancer Therapeutics Revenue, 2018-2032
6.4.2 Germany Bladder Cancer Therapeutics Market Size, 2018-2032
6.4.3 France Bladder Cancer Therapeutics Market Size, 2018-2032
6.4.4 U.K. Bladder Cancer Therapeutics Market Size, 2018-2032
6.4.5 Italy Bladder Cancer Therapeutics Market Size, 2018-2032
6.4.6 Russia Bladder Cancer Therapeutics Market Size, 2018-2032
6.4.7 Nordic Countries Bladder Cancer Therapeutics Market Size, 2018-2032
6.4.8 Benelux Bladder Cancer Therapeutics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Bladder Cancer Therapeutics Revenue, 2018-2032
6.5.2 China Bladder Cancer Therapeutics Market Size, 2018-2032
6.5.3 Japan Bladder Cancer Therapeutics Market Size, 2018-2032
6.5.4 South Korea Bladder Cancer Therapeutics Market Size, 2018-2032
6.5.5 Southeast Asia Bladder Cancer Therapeutics Market Size, 2018-2032
6.5.6 India Bladder Cancer Therapeutics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Bladder Cancer Therapeutics Revenue, 2018-2032
6.6.2 Brazil Bladder Cancer Therapeutics Market Size, 2018-2032
6.6.3 Argentina Bladder Cancer Therapeutics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bladder Cancer Therapeutics Revenue, 2018-2032
6.7.2 Turkey Bladder Cancer Therapeutics Market Size, 2018-2032
6.7.3 Israel Bladder Cancer Therapeutics Market Size, 2018-2032
6.7.4 Saudi Arabia Bladder Cancer Therapeutics Market Size, 2018-2032
6.7.5 UAE Bladder Cancer Therapeutics Market Size, 2018-2032
7 Bladder Cancer Therapeutics Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Bladder Cancer Therapeutics Major Product Offerings
7.1.4 Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Bladder Cancer Therapeutics Major Product Offerings
7.2.4 Eli Lilly Bladder Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 F. Hoffman-La Roche
7.3.1 F. Hoffman-La Roche Company Summary
7.3.2 F. Hoffman-La Roche Business Overview
7.3.3 F. Hoffman-La Roche Bladder Cancer Therapeutics Major Product Offerings
7.3.4 F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 F. Hoffman-La Roche Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Bladder Cancer Therapeutics Major Product Offerings
7.4.4 Pfizer Bladder Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Bladder Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Bladder Cancer Therapeutics Market Drivers in Global Market
Table 3. Bladder Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Bladder Cancer Therapeutics in Global Market
Table 5. Top Bladder Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bladder Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bladder Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bladder Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Bladder Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bladder Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bladder Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Bladder Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bladder Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Bladder Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Bladder Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bladder Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Bladder Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Bladder Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bladder Cancer Therapeutics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bladder Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bladder Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bladder Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bladder Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bladder Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 30. Bristol-Myers Squibb Company Summary
Table 31. Bristol-Myers Squibb Bladder Cancer Therapeutics Product Offerings
Table 32. Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Bladder Cancer Therapeutics Product Offerings
Table 36. Eli Lilly Bladder Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. F. Hoffman-La Roche Company Summary
Table 39. F. Hoffman-La Roche Bladder Cancer Therapeutics Product Offerings
Table 40. F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffman-La Roche Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Bladder Cancer Therapeutics Product Offerings
Table 44. Pfizer Bladder Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Bladder Cancer Therapeutics Segment by Type in 2022
Figure 2. Bladder Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Bladder Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bladder Cancer Therapeutics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Bladder Cancer Therapeutics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bladder Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Bladder Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Bladder Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 16. US Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 20. Germany Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 21. France Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 28. China Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 32. India Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 34. Brazil Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Bladder Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 37. Turkey Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Bladder Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 41. Bristol-Myers Squibb Bladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Bladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffman-La Roche Bladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Bladder Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
